{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:09:33Z","timestamp":1790856573636,"version":"4.1.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The oncoprotein Tax of human T-cell leukemia virus type I (HTLV-1) is the major mediator of viral pathogenesis in infected individuals. Expression of Tax under the regulation of the human granzyme B promoter in mice results in a lymphoproliferative disorder resembling adult T-cell leukemia\/lymphoma (ATL). Tax expression is associated with the production of high levels interferon-\u03b3 (IFN-\u03b3) in HTLV-1-infected CD4+ cells and Tax-transgenic tumors. We examined the role of IFN-\u03b3 in tumorigenesis, by mating Tax-transgenic mice with a gene-specific knockout for IFN-\u03b3. IFN-\u03b3-\/- Tax+-transgenic mice show accelerated tumor onset (median, 4 versus 6 months), dissemination (median, 5 versus 7 months), and death (median, 7 versus 10 months), compared with IFN-\u03b3+\/- or IFN-\u03b3+\/+ Tax+ mice. Pathologic and immunophenotypic characteristics of tumors from all genotypes are indistinguishable, except for enhanced interleukin 2 receptor-\u03b2 (IL-2R\u03b2) and suppressed intercellular adhesion molecule-1 (ICAM-1) expression on tumors from IFN-\u03b3-\/- Tax+ transgenic mice. IFN-\u03b3-\/- tumors demonstrate enhanced CD31 (platelet-endothelial CAM-1 [PECAM-1]) staining compared with those from IFN-\u03b3+\/- or IFN-\u03b3+\/+ Tax+ mice. Angiogenesis-specific cDNA microarray analysis identified 4 mediators of angiogenic growth differentially expressed in tumors from Tax+IFN-\u03b3-\/- mice compared with Tax+IFN-\u03b3+\/+ littermates. As confirmed by reverse transcription-polymerase chain reaction (RT-PCR), loss of IFN-\u03b3 results in down-regulation of tumor necrosis factor-\u03b1 (TNF-\u03b1) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) while up-regulating expression of vascular endothelial growth factor (VEGF) and tenascin C. These results provide insight into a possible mechanism by which IFN-\u03b3 contributes to host resistance against HTLV-induced tumors through an angiostatic effect. (Blood. 2004;104:3305-3311)<\/jats:p>","DOI":"10.1182\/blood-2004-01-0266","type":"journal-article","created":{"date-parts":[[2004,8,4]],"date-time":"2004-08-04T01:08:45Z","timestamp":1091581725000},"page":"3305-3311","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":53,"title":["Enhanced tumorigenesis in HTLV-1 Tax-transgenic mice deficient in interferon-gamma"],"prefix":"10.1182","volume":"104","author":[{"given":"Shibani","family":"Mitra-Kaushik","sequence":"first","affiliation":[{"name":"From the Departments of Internal Medicine, Molecular Microbiobology, and Pathology, Washington University School of Medicine, St Louis, MO; and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Harding","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine, Molecular Microbiobology, and Pathology, Washington University School of Medicine, St Louis, MO; and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Hess","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine, Molecular Microbiobology, and Pathology, Washington University School of Medicine, St Louis, MO; and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schreiber","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine, Molecular Microbiobology, and Pathology, Washington University School of Medicine, St Louis, MO; and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine, Molecular Microbiobology, and Pathology, Washington University School of Medicine, St Louis, MO; and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222403929100_REF1","doi-asserted-by":"crossref","unstructured":"Bangham CR. HTLV-1 infections. J Clin Pathol. 2000;53: 581-586.","DOI":"10.1136\/jcp.53.8.581"},{"key":"2020021222403929100_REF2","doi-asserted-by":"crossref","unstructured":"Blattner WA. Human retroviruses: their role in cancer. Proc Assoc Am Physicians. 1999;111: 563-572.","DOI":"10.1046\/j.1525-1381.1999.99210.x"},{"key":"2020021222403929100_REF3","doi-asserted-by":"crossref","unstructured":"Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997;15: 15-37.","DOI":"10.1146\/annurev.immunol.15.1.15"},{"key":"2020021222403929100_REF4","doi-asserted-by":"crossref","unstructured":"Xiao G, Cvijic ME, Fong A, et al. Retroviral oncoprotein Tax induces processing of NF-kappaB2\/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 2001;20: 6805-6815.","DOI":"10.1093\/emboj\/20.23.6805"},{"key":"2020021222403929100_REF5","doi-asserted-by":"crossref","unstructured":"Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol. 2001;19: 475-496.","DOI":"10.1146\/annurev.immunol.19.1.475"},{"key":"2020021222403929100_REF6","doi-asserted-by":"crossref","unstructured":"Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Brady JN. Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent. J Biol Chem. 2001;276: 200-205.","DOI":"10.1074\/jbc.M005601200"},{"key":"2020021222403929100_REF7","doi-asserted-by":"crossref","unstructured":"Pise-Masison CA, Mahieux R, Radonovich M, et al. Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax. AIDS Res Hum Retroviruses. 2000;16: 1669-1675.","DOI":"10.1089\/08892220050193128"},{"key":"2020021222403929100_REF8","doi-asserted-by":"crossref","unstructured":"Giebler HA, Loring JE, van Orden K, et al. Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation. Mol Cell Biol. 1997;17: 5156-5164.","DOI":"10.1128\/MCB.17.9.5156"},{"key":"2020021222403929100_REF9","doi-asserted-by":"crossref","unstructured":"Sun SC, Elwood J, Beraud C, Greene WC. Human T-cell leukemia virus type I Tax activation of NF-kappa B\/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene. Mol Cell Biol. 1994;14: 7377-7384.","DOI":"10.1128\/MCB.14.11.7377"},{"key":"2020021222403929100_REF10","doi-asserted-by":"crossref","unstructured":"Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1995;92: 1057-1061.","DOI":"10.1073\/pnas.92.4.1057"},{"key":"2020021222403929100_REF11","doi-asserted-by":"crossref","unstructured":"Grossman WJ, Ratner L. Cytokine expression and tumorigenicity of large granular lymphocytic leukemia cells from mice transgenic for the tax gene of human T-cell leukemia virus type I. Blood. 1997;90: 783-794.","DOI":"10.1182\/blood.V90.2.783"},{"key":"2020021222403929100_REF12","doi-asserted-by":"crossref","unstructured":"Alexandroff AB, McIntyre CA, Porter JC, Zeuthen J, Vile RG, Taub DD. Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer. Br J Cancer. 1998;77: 1806-1811.","DOI":"10.1038\/bjc.1998.300"},{"key":"2020021222403929100_REF13","doi-asserted-by":"crossref","unstructured":"Kodaka T, Uchiyama T, Umadome H, Uchino H. Expression of cytokine mRNA in leukemic cells from adult T cell leukemia patients. Jpn J Cancer Res. 1989;80: 531-536.","DOI":"10.1111\/j.1349-7006.1989.tb01672.x"},{"key":"2020021222403929100_REF14","doi-asserted-by":"crossref","unstructured":"Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1994;53: 72-77.","DOI":"10.1097\/00005072-199401000-00009"},{"key":"2020021222403929100_REF15","doi-asserted-by":"crossref","unstructured":"Ichinose K, Nakamura T, Nishiura Y, et al. Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy. J Neurol Sci. 1994;122: 204-209.","DOI":"10.1016\/0022-510X(94)90299-2"},{"key":"2020021222403929100_REF16","doi-asserted-by":"crossref","unstructured":"Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002;13: 95-109.","DOI":"10.1016\/S1359-6101(01)00038-7"},{"key":"2020021222403929100_REF17","doi-asserted-by":"crossref","unstructured":"Street SE, Trapani JA, MacGregor D, Smyth MJ. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med. 2002;196: 129-134.","DOI":"10.1084\/jem.20020063"},{"key":"2020021222403929100_REF18","doi-asserted-by":"crossref","unstructured":"Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993;259: 1739-1742.","DOI":"10.1126\/science.8456300"},{"key":"2020021222403929100_REF19","doi-asserted-by":"crossref","unstructured":"Schreiber RD, Hicks LJ, Celada A, Buchmeier NA, Gray PW. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. J Immunol. 1985;134: 1609-1618.","DOI":"10.4049\/jimmunol.134.3.1609"},{"key":"2020021222403929100_REF20","doi-asserted-by":"crossref","unstructured":"Ahn EY, Pan G, Vickers SM, McDonald JM. IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int J Cancer. 2002;100: 445-451.","DOI":"10.1002\/ijc.10516"},{"key":"2020021222403929100_REF21","doi-asserted-by":"crossref","unstructured":"Andrews HN, Mullan PB, McWilliams S, et al. BRCA1 regulates the interferon gamma-mediated apoptotic response. J Biol Chem. 2002;277: 26225-26232.","DOI":"10.1074\/jbc.M201316200"},{"key":"2020021222403929100_REF22","doi-asserted-by":"crossref","unstructured":"Kaplan DH, Shankaran V, Dighe AS, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A. 1998;95: 7556-7561.","DOI":"10.1073\/pnas.95.13.7556"},{"key":"2020021222403929100_REF23","doi-asserted-by":"crossref","unstructured":"Dighe AS, Richards E, Old LJ, Schreiber RD. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity. 1994;1: 447-456.","DOI":"10.1016\/1074-7613(94)90087-6"},{"key":"2020021222403929100_REF24","doi-asserted-by":"crossref","unstructured":"Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol. 1997;15: 749-795.","DOI":"10.1146\/annurev.immunol.15.1.749"},{"key":"2020021222403929100_REF25","doi-asserted-by":"crossref","unstructured":"Billiau A, Heremans H, Vermeire K, Matthys P. Immunomodulatory properties of interferon-gamma: an update. Ann N Y Acad Sci. 1998;856: 22-32.","DOI":"10.1111\/j.1749-6632.1998.tb08309.x"},{"key":"2020021222403929100_REF26","doi-asserted-by":"crossref","unstructured":"Hawley RG, Berger LC. Growth control mechanisms in multiple myeloma. Leuk Lymphoma. 1998;29: 465-475.","DOI":"10.3109\/10428199809050906"},{"key":"2020021222403929100_REF27","doi-asserted-by":"crossref","unstructured":"Dai C, Krantz SB. Interferon gamma induces up-regulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood. 1999;93: 3309-3316.","DOI":"10.1182\/blood.V93.10.3309.410k04_3309_3316"},{"key":"2020021222403929100_REF28","doi-asserted-by":"crossref","unstructured":"Tamura T, Ishihara M, Lamphier MS, et al. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature. 1995;376: 596-599.","DOI":"10.1038\/376596a0"},{"key":"2020021222403929100_REF29","doi-asserted-by":"crossref","unstructured":"Coughlin CM, Salhany KE, Gee MS, et al. Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity. 1998;9: 25-34.","DOI":"10.1016\/S1074-7613(00)80585-3"},{"key":"2020021222403929100_REF30","doi-asserted-by":"crossref","unstructured":"Yao L, Sgadari C, Furuke K, Bloom ET, Teruya-Feldstein J, Tosato G. Contribution of natural killer cells to inhibition of angiogenesis by inter-leukin-12. Blood. 1999;93: 1612-1621.","DOI":"10.1182\/blood.V93.5.1612"},{"key":"2020021222403929100_REF31","doi-asserted-by":"crossref","unstructured":"Brown DA, Nelson FB, Reinherz EL, Diamond DJ. The human interferon-gamma gene contains an inducible promoter that can be transactivated by tax I and II. Eur J Immunol. 1991;21: 1879-1885.","DOI":"10.1002\/eji.1830210815"},{"key":"2020021222403929100_REF32","doi-asserted-by":"crossref","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLVI-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol. 1998;161: 482-488.","DOI":"10.4049\/jimmunol.161.1.482"},{"key":"2020021222403929100_REF33","doi-asserted-by":"crossref","unstructured":"Owen SM, Rudolph DL, Dezzutti CS, et al. Transcriptional activation of the intercellular adhesion molecule 1 (CD54) gene by human T lymphotropic virus types I and II Tax is mediated through a palindromic response element. AIDS Res Hum Retroviruses. 1997;13: 1429-1437.","DOI":"10.1089\/aid.1997.13.1429"},{"key":"2020021222403929100_REF34","doi-asserted-by":"crossref","unstructured":"Beatty G, Paterson Y. IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma. J Immunol. 2001;166: 2276-2282.","DOI":"10.4049\/jimmunol.166.4.2276"},{"key":"2020021222403929100_REF35","doi-asserted-by":"crossref","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285: 1182-1186.","DOI":"10.1056\/NEJM197111182852108"},{"key":"2020021222403929100_REF36","doi-asserted-by":"crossref","unstructured":"Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1: 27-31.","DOI":"10.1038\/nm0195-27"},{"key":"2020021222403929100_REF37","unstructured":"Qin Z, Schwartzkopff J, Pradera F, et al. A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells. Cancer Res. 2003;63: 4095-4100."},{"key":"2020021222403929100_REF38","doi-asserted-by":"crossref","unstructured":"Beatty GL, Paterson Y. Regulation of tumor growth by IFN-gamma in cancer immunotherapy. Immunol Res. 2001;24: 201-210.","DOI":"10.1385\/IR:24:2:201"},{"key":"2020021222403929100_REF39","unstructured":"Hayakawa Y, Takeda K, Yagita H, et al. IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. Blood. 2002;100: 1728-1733."},{"key":"2020021222403929100_REF40","doi-asserted-by":"crossref","unstructured":"Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med. 1998;49: 407-424.","DOI":"10.1146\/annurev.med.49.1.407"},{"key":"2020021222403929100_REF41","doi-asserted-by":"crossref","unstructured":"Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86: 353-364.","DOI":"10.1016\/S0092-8674(00)80108-7"},{"key":"2020021222403929100_REF42","doi-asserted-by":"crossref","unstructured":"Qin Z, Blankenstein T. CD4+ T cell\u2014mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity. 2000;12: 677-686.","DOI":"10.1016\/S1074-7613(00)80218-6"},{"key":"2020021222403929100_REF43","doi-asserted-by":"crossref","unstructured":"Fathallah-Shaykh HM, Zhao LJ, Kafrouni AI, Smith GM, Forman J. Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis. J Immunol. 2000;164: 217-222.","DOI":"10.4049\/jimmunol.164.1.217"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3305\/1703288\/zh802204003305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3305\/1703288\/zh802204003305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T03:56:48Z","timestamp":1682740608000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/10\/3305\/18734\/Enhanced-tumorigenesis-in-HTLV1-Taxtransgenic-mice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,15]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-01-0266","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,15]]}}}